Background: We hypothesized that the difference between the prescribed end-dialysis body weight, defined end-dialysis over-weight (edOW; kg), and the body weight which is actually attained could impact survival in hemodialysis (HD) patients. The aim of this prospective observational study was to evaluate if edOW could influence survival in a cohort of prevalent HD patients, controlled for multiple dialysis and clinical risk factors and followed for 3 years. Methods: One hundred and eighty-two patients (117 men, age 65 ± 13 years) on regular HD treatment for at least 6 months [median 48 months (range: 6-366)] were followed from January 1, 2008 to December 31, 2010. Eighty-four patients (46%) did not achieve their prescribed dry body weight (dBW); their median edOW was 0.4 kg (range: 0.1-1.4). Ninety-eight died during observation, mainly from cardiovascular reasons (69%). Multivariate Cox regression analysis was utilized to evaluate the effect edOW, ultrafiltration rate (UFR), interdialytic weight gain (IDWG), age, sex, dialytic vintage, cardiovascular disease, antihypertensive therapy, diabetes, duration of HD, dBW, BMI, mean arterial blood pressure, Kt/V, and protein catabolic rate (PCRn) had on mortality. Results: Age (HR: 1.04; CI: 1.03-1.05; p <0.0001), IDWG (HR: 2.62; CI: 2.06-3.34; p < 0.01), UFR (HR: 1.13; CI: 1.09-1.16; p< 0.01), PCRn (HR: 0.02; CI: 0.01-0.04; p <0.001), and edOW (HR: 2.71; CI: 1.95-3.75; p < 0.02) were independently correlated to survival. The relative receiver operating characteristic curve identified a cutoff value of 0.3 kg for edOW in predicting death. Conclusions: High edOW is independently associated with an increased long-term risk of all-cause and cardiovascular mortality in HD patients. Better survival was observed in patients with edOW <0.3 kg. For patients with higher edOW, longer or more frequent dialysis sessions should be considered in order to prevent the deleterious consequences of excessive body fluid expansion.

Keywords:
Hemodialysis, Survival, Interdialytic weight gain, Ultrafiltration rate, End-dialysis overweight
1.
Charra B: ‘Dry weight' in dialysis: the history of a concept. Nephrol Dial Transplant 1998;7:1882-1885.
2.
Agarwal R, Weir MR: Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 2010;5:1255-1260.
3.
Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-1315.
4.
Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-S119.
5.
Sarkar SR, Kotanko P, Levin NW: Interdialytic weight gain: implications in hemodialysis patients. Semin Dial 2006;19:429-433.
6.
Jaeger JQ, Metha RL: Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 1999;10:392-403.
7.
Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 2009;4:914-920.
8.
Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009;4:1925-1931.
9.
Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fisher MS, Londrino F, Cancarini G: Association between a high ultrafiltration rates and mortality in uremic patients on regular hemodialysis. A 5-year prospective observational multicenter study. Nephrol Dial Transplant 2007;22:3547-3552.
10.
Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011;79:250-257.
11.
Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horowich TB, Fonarow GC: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119:671-679.
12.
Holmberg B, Stegmayr BG: Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain. Hemodial Int 2009;13:27-31.
13.
Lopez-Gomez JM, Villaverde M, Jofre R, Rodriguez-Benitez P, Perez-Garcia R: Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int Suppl 2005;67:S63-S68.
14.
Daugirdas JT: Second generation logarithmic estimates of single pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-1213.
15.
NKF-K/DOQI Nutrition Work Group: Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. New York, National Kidney Foundation, 2001, pp 75-80.
16.
Flythe JE, Kunaparaju S, Dinesh K, Cape K, Feldman HI, Brunelli SM: Factors associated with intradialytic systolic blood pressure variability. Am J Kidney Dis 2012;59:409-418.
17.
Mistiaen P: Thirst, interdialytic weight gain, and thirst interventions in hemodialysis patients: a literature review. Nephrol Nurs J 2001;28:601-604.
18.
Sherman RA, Cody RP, Rogers ME, Solanchick JC: Interdialytic weight gain and nutritional parameters in chronic hemodialysis patients. Am J Kidney Dis 1995;25:579-583.
19.
Wizemann W, Wabel P, Chamney P, Wojciech Z, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in hemodialysis patients. Nephrol Dial Transplant 2009;24:1574-1579.
20.
Davenport A: Interdialytic weight gain in diabetic haemodialysis patients and diabetic control as assessed by glycated haemoglobin. Nephron Clin Pract 2009;113:c33-c37.
21.
FHN Trial Group: In-center hemodialysis six times per week versus three times per week. New Engl J Med 2010;363:2287-2300.
22.
Ramkumar N, Bebbhu S, Eggers P, Pappas LM, Cheung AK: Patient preferences for in-center intense hemodialysis. Hemodial Int 2005;9:281-295.
23.
Sharp J, Wild MR, Gumley AI: A systematic review of psychological interventions for the treatment of nonadherence to fluid-intake restrictions in people receiving hemodialysis. Am J Kidney Dis 2005;45:15-27.
24.
Canaud B, Lertdumrongluk P: Probing ‘dry weight' in hemodialysis patients: ‘back to the future'. Nephrol Dial Transplant 2012;27:2140-2143.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.